Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Sadler, J. E.
  • Budde, U.
  • Eikenboom, J. C. J.
  • Favaloro, E. J.
  • Hill, F. G. H.
  • Holmberg, L.
  • Ingerslev, J.
  • Lee, C. A.
  • Lillicrap, D.
  • Mannucci, M.
  • Mazurier, C.
  • Meyer, D.
  • Nichols, W. L.
  • Nishino, M.
  • Peake, I. R.
  • Rodeghiero, F.
  • Schneppenheim, R.
  • Ruggeri, Zaverio
  • Srivastava, A.
  • Montgomery, R. R.
  • Federici, A. B.
  • The Working Party on von Willebrand Disease Classification

publication date

  • October 2006

journal

  • Journal of Thrombosis and Haemostasis  Journal

abstract

  • von Willebrand disease (VWD) is a bleeding disorder caused by inherited defects in the concentration, structure, or function of von Willebrand factor (VWF). VWD is classified into three primary categories. Type 1 includes partial quantitative deficiency, type 2 includes qualitative defects, and type 3 includes virtually complete deficiency of VWF. VWD type 2 is divided into four secondary categories. Type 2A includes variants with decreased platelet adhesion caused by selective deficiency of high-molecular-weight VWF multimers. Type 2B includes variants with increased affinity for platelet glycoprotein Ib. Type 2M includes variants with markedly defective platelet adhesion despite a relatively normal size distribution of VWF multimers. Type 2N includes variants with markedly decreased affinity for factor VIII. These six categories of VWD correlate with important clinical features and therapeutic requirements. Some VWF gene mutations, alone or in combination, have complex effects and give rise to mixed VWD phenotypes. Certain VWD types, especially type 1 and type 2A, encompass several pathophysiologic mechanisms that sometimes can be distinguished by appropriate laboratory studies. The clinical significance of this heterogeneity is under investigation, which may support further subdivision of VWD type 1 or type 2A in the future.

subject areas

  • ADAM Proteins
  • Humans
  • Models, Biological
  • Phenotype
  • Protein Structure, Tertiary
  • von Willebrand Diseases
  • von Willebrand Factor
scroll to property group menus

Research

keywords

  • ADAMTS-13
  • classification
  • pathophysiology
  • von Willebrand disease
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 1538-7933

Digital Object Identifier (DOI)

  • 10.1111/j.1538-7836.2006.02146.x

PubMed ID

  • 16889557
scroll to property group menus

Additional Document Info

start page

  • 2103

end page

  • 2114

volume

  • 4

issue

  • 10

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support